News

2020

• June 19, 2020

  Domain presents the last generation of bioSens-All™ platform dedicated to checkpoint inhibitors at the AACR 2020

  Read more
• June 19, 2020

  Domain presents a novel approach to study RTK mutations and the effects of inhibitors at the AACR 2020

  Read more
• June 19, 2020

  Domain presents target identification strategy to identify novel immune checkpoint from GPCR-ome at the AACR 2020

  Read more
• June 19, 2020

  Domain presents the best-in-class potential of its EP4 antagonist drug candidate at the AACR 2020

  Read more
• June 10, 2020

  Domain Therapeutics contributes to the launch of Find Therapeutics

  Read more
• June 9, 2020

  DOMAIN at the BIO Digital conference 2020

  Read more
• April 10, 2020

  Domain at the BioTrinity 2020 digital conference

  Read more
• January 13, 2020

  Domain at the JP Morgan Healthcare conference

  Read more